Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear pore complex interacting protein family member B7 (NPIPB7) is a predicted protein in humans encoded by the NPIPB7 gene (HGNC:33832, Gene ID:440350). It is proposed to localize to the nuclear pore complex, a large structure in the nuclear envelope that regulates molecular traffic between the nucleus and cytoplasm; however, there is no direct experimental confirmation of its biological function or disease association. Protein family assignment places it among nuclear pore complex-interacting proteins, suggesting possible involvement in nucleocytoplasmic transport, but NPIPB7 is not part of the core nucleoporin subunits that are critical for established nuclear pore complex functions. There is no clinical evidence, disease association, or therapeutic targeting of NPIPB7 currently reported.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear pore complex interacting protein family member B7 (NPIPB7).